Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Emerging Biopharma
Biotech
Goa Tx launches with vision of creating Narcan for alcohol
GOA26 mimics the body's natural alcohol digestion process, and has already proven effective in rats and pigs.
Darren Incorvaia
Sep 17, 2026 3:30pm
Sling reels in $123M to fund oral Tepezza rival through ph. 3
Sep 16, 2026 7:00am
Mass. governor acknowledges biotech capital 'harder to come by'
Sep 10, 2026 10:15am
Lilly inks $2.88B Merida buyout to expand autoimmune pipeline
Aug 31, 2026 9:18am
Pfizer vet debuts Khartis with sights set on thyroid eye disease
Aug 13, 2026 9:00am
Epicrispr bags $90M to rewrite treatment of rare muscle disease
Aug 11, 2026 10:30am
More News
Caldera hits Nasdaq via Synlogic reverse merger
Jul 29, 2026 8:56am
Lupin seeds US spinout with cash, clinical-stage cancer assets
Jul 21, 2026 8:20am
Biotechs forced to learn new patent tricks to protect pipelines
Jul 12, 2026 12:00pm
Beeline bolsters autoimmune ambitions with $126M
Jun 30, 2026 7:00am
See more stories